PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 25, 1996New England Journal of Medicine336 citationsOpen Access

Cisapride and Fatal Arrhythmia

View Full Paper
DWDiane K. WysowskiJBJanos T Bacsanyi

Structured PICO

Is cisapride associated with fatal arrhythmias?

P
Population
Patients reported to the Food and Drug Administration's MedWatch system from September 1993 to April 1996
I
Intervention
Cisapride
O
Outcome
Fatal arrhythmiasafety

Early post-marketing surveillance data from the FDA MedWatch system highlighted a risk of fatal arrhythmias associated with cisapride.

Abstract

To the Editor: From September 1993, the month in which the marketing of cisapride (Propulsid, Janssen Pharmaceutica, Titusville, N.J.) began, to April 1996, the Food and Drug Administration's MedWa...

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wysowski et al. (1996) studied this question.

synapsesocial.com/papers/6a753a5e9c92392688b20b04https://doi.org/10.1056/nejm199607253350416
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions2001 · 238 citations
  2. 2Contraindicated Use of Cisapride2000 · 256 citations
  3. 3Cisapride and ventricular arrhythmia2008 · 53 citations
  4. 4Does Cisapride Influence Cardiac Rhythm? Results of a United States Multicenter, Double‐Blind, Placebo‐Controlled Pediatric Study2001 · 4 citations
  5. 5Does Cisapride Influence Cardiac Rhythm? Results of a United States Multicenter, Double-Blind, Placebo-Controlled Pediatric Study2001 · 35 citations